Biologicals

Papers
(The H4-Index of Biologicals is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops25
Aims and Scope/Editorial Board/Publishing Details23
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA20
Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products17
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop14
Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA13
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency13
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis12
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model12
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression11
Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines10
Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions10
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques10
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report10
0.060997009277344